Evaluation of a Commercial Vaccine to Protect Developing Fetuses from Natural Challenges with Bovine Viral Diarrhea Virus and Bovine Herpesvirus 1

Authors

  • M. D. Givens Department of Pathobiology, Auburn University, Auburn, AL 36849
  • M. S. D. Marley Department of Pathobiology, Auburn University, Auburn, AL 36849
  • C. A. Jones Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
  • D. Ensley Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
  • K. S. Joiner Department of Pathobiology, Auburn University, Auburn, AL 36849
  • S. P. Rodning Department of Animal Sciences, Auburn University, Auburn, AL 36849

DOI:

https://doi.org/10.21423/aabppro20104172

Keywords:

Fetal protection, modified-live vaccine, persistently infected, BVDV, bovine herpesvirus 1

Abstract

Fetal protection in heifers vaccinated with a modified-live vaccine (Express® FPS, Boehringer Ingelheim Vetmedica) was evaluated following sequential, prolonged field exposures to animals persistently infected (PI) with bovine viral diarrhea virus (BVDV) and animals acutely infected with bovine herpesvirus 1 (BoHV-1).

Cover image of the 43rd Conference Proceedings: Two short-horned cattle grazing in a field, surrounded by a flock of egrets. Yellow background.

Downloads

Published

2010-08-19

Issue

2010

Section

Posters

Most read articles by the same author(s)

<< < 1 2